4//SEC Filing
Nabulsi Azmi 4
Accession 0001209191-22-029453
CIK 0001783183other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 8:48 PM ET
Size
6.5 KB
Accession
0001209191-22-029453
Insider Transaction Report
Form 4
Nabulsi Azmi
Chief Operating Officer
Transactions
- Purchase
Common Stock
2022-05-16$8.16/sh+20,000$163,288→ 785,700 total(indirect: By Trust)
Holdings
- 21,378
Common Stock
- 843.42(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.00 to $8.43. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001791412
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 8:48 PM ET
- Size
- 6.5 KB